Patent · US Active

Encapsulated tiotropium containing powder formulation for inhalation

US8197845B2 · kind B2 · utility

3Cited by

28References

4Claims

0Family size

Assignee

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

Mareke Hartig · Ingelheim am Rhein, DE
Michael Trunk · Ingelheim am Rhein, DE
Michael Walz · Friedberg, DE

Key dates

Filing date	Jul 24, 2009
Grant date	Jun 12, 2012
Priority date	—
Expiry date	May 31, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2202/064
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to powdered preparations containing tiotropium for inhalation, processes for preparing them as well as their use in preparing a pharmaceutical composition for the treatment of respiratory complaints, particularly for the treatment of COPD (chronic obstructive pulmonary disease) and asthma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.